InvestorsHub Logo
Followers 33
Posts 5319
Boards Moderated 0
Alias Born 01/23/2019

Re: None

Thursday, 09/03/2020 11:06:44 AM

Thursday, September 03, 2020 11:06:44 AM

Post# of 429108
30 days to file a petition for En Banc review. So is this a good thing? Or a waste of time and money?

BRIEF-Amarin Provides Update Following Ruling In Vascepa ANDA Patent Litigation
REUTERS 10:57 AM ET 9/3/2020
Symbol Last Price Change
AMRN 4.84down -0.2 (-3.97%)
QUOTES AS OF 11:04:43 AM ET 09/03/2020
Sept 3 (Reuters) - Amarin Corporation PLC(AMRN):

* AMARIN PROVIDES UPDATE FOLLOWING RULING IN VASCEPA® ANDA PATENT LITIGATION

* AMARIN(AMRN) - CURRENTLY REVIEWING ITS LEGAL OPTIONS AND WITHIN 30 DAYS EXPECTS TO FILE A PETITION FOR AN EN BANC REVIEW OF CURRENT PANEL DECISION

* AMARIN CORPORATION PLC(AMRN) - INTENDS TO CONTINUE CURRENT PROMOTION LEVELS OF VASCEPA IN UNITED STATES

* AMARIN CORPORATION PLC(AMRN) - ANTICIPATES THAT GENERICS COMPANIES, WHEN THEY LAUNCH IN U.S., ARE LIKELY TO HAVE LIMITED SUPPLY CAPACITY FOR VASCEPA Source text for Eikon: Further company coverage:

(c) Copyright Thomson Reuters 2020. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News